Stock VYCO VYCOR MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vycor Medical, Inc.

Equities

VYCO

US92921M2035

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 03:52:19 2024-04-09 pm EDT 		5-day change 1st Jan Change
0.084 USD 0.00% Intraday chart for Vycor Medical, Inc. 0.00% +8.81%
Apr. 16 Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1.854 3.423 2.687 3.013 2.928 2.519
Enterprise Value (EV) 1 2.286 3.937 3.608 3.79 3.885 3.572
P/E ratio -1.04 x -2.96 x -2.27 x -3.82 x -3.91 x -6.39 x
Yield - - - - - -
Capitalization / Revenue 1.23 x 2.31 x 2.35 x 2.16 x 2.39 x 1.72 x
EV / Revenue 1.51 x 2.66 x 3.16 x 2.72 x 3.18 x 2.45 x
EV / EBITDA -2.74 x -6 x -5.39 x -10.3 x -15.9 x 35.4 x
EV / FCF 13.2 x 6.85 x 10.9 x 7.19 x 15.2 x 9.49 x
FCF Yield 7.6% 14.6% 9.19% 13.9% 6.56% 10.5%
Price to Book -2.47 x -2.58 x -1.38 x -1.26 x -1 x -0.76 x
Nbr of stocks (in thousands) 22,605 24,753 26,896 30,749 32,527 32,629
Reference price 2 0.0820 0.1383 0.0999 0.0980 0.0900 0.0772
Announcement Date 3/29/19 3/27/20 3/31/21 4/13/22 4/14/23 4/16/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1.509 1.482 1.142 1.393 1.223 1.461
EBITDA 1 -0.8328 -0.6557 -0.6695 -0.3675 -0.2451 0.1009
EBIT 1 -1.01 -0.7251 -0.7274 -0.436 -0.3065 0.0402
Operating Margin -66.93% -48.94% -63.69% -31.3% -25.06% 2.75%
Earnings before Tax (EBT) 1 -1.379 -0.7962 -0.8003 -0.4082 -0.3997 -0.0631
Net income 1 -1.379 -0.7962 -0.8225 -0.4357 -0.4049 -0.0697
Net margin -91.39% -53.73% -72.02% -31.28% -33.11% -4.77%
EPS 2 -0.0789 -0.0468 -0.0439 -0.0257 -0.0230 -0.0121
Free Cash Flow 1 0.1738 0.5747 0.3317 0.5274 0.255 0.3765
FCF margin 11.51% 38.78% 29.04% 37.86% 20.85% 25.78%
FCF Conversion (EBITDA) - - - - - 373.03%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/19 3/27/20 3/31/21 4/13/22 4/14/23 4/16/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.43 0.51 0.92 0.78 0.96 1.05
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.5191 x -0.7849 x -1.376 x -2.113 x -3.904 x 10.43 x
Free Cash Flow 1 0.17 0.57 0.33 0.53 0.26 0.38
ROE (net income / shareholders' equity) 401% 75% 48% 18.7% 15% 2.01%
ROA (Net income/ Total Assets) -50.6% -42.4% -43.7% -28.4% -21.3% 2.71%
Assets 1 2.724 1.876 1.88 1.536 1.898 -2.57
Book Value Per Share 2 -0.0300 -0.0500 -0.0700 -0.0800 -0.0900 -0.1000
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 0.06 0.06 0.06 0.04 0 0.01
Capex / Sales 4.21% 3.93% 5.43% 2.75% 0.23% 0.64%
Announcement Date 3/29/19 3/27/20 3/31/21 4/13/22 4/14/23 4/16/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
VYCOR MEDICAL, INC. Stock Vycor Medical, Inc.
+8.81% 2.74M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. VYCO Stock
  4. Financials Vycor Medical, Inc.